control igg igg2a isotype control clone 2a3 antibody (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
90
Structured Review
Bio X Cell
control igg igg2a isotype control clone 2a3 antibody
Control Igg Igg2a Isotype Control Clone 2a3 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+igg+igg2a+isotype+control+clone+2a3+antibody/anti+cd4+gk1+5/pm37525015-265-16-24
Average 90 stars, based on 1 article reviews
Control Igg Igg2a Isotype Control Clone 2a3 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+igg+igg2a+isotype+control+clone+2a3+antibody/anti+cd4+gk1+5/pm37525015-265-16-24
Average 90 stars, based on 1 article reviews
control igg igg2a isotype control clone 2a3 antibody - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Injection:Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: control IgG (IgG2a isotype control clone 2A3, BioXCell, 10 mg per kg body weight, 3× per week) anti-CTLA-4 antibody (anti-mouse CTLA-4 clone 9D9, BioXCell, 8 mg per kg body weight, 3× per week), Control:Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: control IgG (IgG2a isotype control clone 2A3, BioXCell, 10 mg per kg body weight, 3× per week) anti-CTLA-4 antibody (anti-mouse CTLA-4 clone 9D9, BioXCell, 8 mg per kg body weight, 3× per week), Recombinant:Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: control IgG (IgG2a isotype control clone 2A3, BioXCell, 10 mg per kg body weight, 3× per week) anti-CTLA-4 antibody (anti-mouse CTLA-4 clone 9D9, BioXCell, 8 mg per kg body weight, 3× per week), Purification:Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: Article Title: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Article Snippet: .. The following treatments in different combinations (total injection volume of 200 μl) were administered by intraperitoneal injection: control IgG (IgG2a isotype control clone 2A3, BioXCell, 10 mg per kg body weight, 3× per week) anti-CTLA-4 antibody (anti-mouse CTLA-4 clone 9D9, BioXCell, 8 mg per kg body weight, 3× per week), |